PL328147A1 - Method of inhibiting colon tumours - Google Patents

Method of inhibiting colon tumours

Info

Publication number
PL328147A1
PL328147A1 PL97328147A PL32814797A PL328147A1 PL 328147 A1 PL328147 A1 PL 328147A1 PL 97328147 A PL97328147 A PL 97328147A PL 32814797 A PL32814797 A PL 32814797A PL 328147 A1 PL328147 A1 PL 328147A1
Authority
PL
Poland
Prior art keywords
colon tumours
inhibiting colon
inhibiting
tumours
colon
Prior art date
Application number
PL97328147A
Other languages
English (en)
Inventor
Maria Luisa Brandi
Francesco Tonelli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL328147A1 publication Critical patent/PL328147A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
PL97328147A 1996-01-29 1997-01-27 Method of inhibiting colon tumours PL328147A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors

Publications (1)

Publication Number Publication Date
PL328147A1 true PL328147A1 (en) 1999-01-18

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97328147A PL328147A1 (en) 1996-01-29 1997-01-27 Method of inhibiting colon tumours

Country Status (19)

Country Link
EP (1) EP0921799A4 (es)
JP (1) JP2000503994A (es)
KR (1) KR19990082054A (es)
CN (1) CN1209745A (es)
AR (1) AR010978A1 (es)
AU (1) AU707892B2 (es)
BR (1) BR9700778A (es)
CO (1) CO4761062A1 (es)
CZ (1) CZ235498A3 (es)
EA (1) EA001104B1 (es)
ID (1) ID15917A (es)
IL (1) IL125521A (es)
MX (1) MX9806036A (es)
NO (1) NO983451D0 (es)
NZ (1) NZ331105A (es)
PL (1) PL328147A1 (es)
TW (1) TW446560B (es)
WO (1) WO1997026877A1 (es)
YU (1) YU2397A (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CA2118096A1 (en) * 1993-10-15 1995-04-16 Srinivasan Chandrasekhar Methods for treating resistant neoplasms
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
AU707892B2 (en) 1999-07-22
YU2397A (en) 1999-11-22
AR010978A1 (es) 2000-08-02
EA199800677A1 (ru) 1999-02-25
TW446560B (en) 2001-07-21
EA001104B1 (ru) 2000-10-30
CN1209745A (zh) 1999-03-03
AU2123997A (en) 1997-08-20
KR19990082054A (ko) 1999-11-15
JP2000503994A (ja) 2000-04-04
EP0921799A1 (en) 1999-06-16
EP0921799A4 (en) 2002-03-13
MX9806036A (es) 1998-11-29
CZ235498A3 (cs) 1999-02-17
NO983451L (no) 1998-07-27
ID15917A (id) 1997-08-21
NZ331105A (en) 2000-06-23
BR9700778A (pt) 1998-10-06
IL125521A (en) 2001-11-25
CO4761062A1 (es) 1999-04-27
WO1997026877A1 (en) 1997-07-31
IL125521A0 (en) 1999-03-12
NO983451D0 (no) 1998-07-27

Similar Documents

Publication Publication Date Title
GB2309723B (en) Improved downhole apparatus
GB2331115B (en) Downhole apparatus
IL125829A0 (en) Method of sharing cryptokey
GB9603677D0 (en) Downhole apparatus
ZA98643B (en) Method for inhibiting the growth of cancers
GB9715295D0 (en) Novel method of treatment
GB9712866D0 (en) Novel method of treatment
GB9707693D0 (en) Novel method of treatment
ZA964682B (en) Methods of inhibiting melanoma.
GB2315082B (en) Downhole apparatus
GB2326658B (en) Treatment of subterranean coal formation
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
GB9715298D0 (en) Novel method of treatment
GB9715306D0 (en) Novel method of treatment
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
ZA989840B (en) Method of inhibiting metastases of cancer cells
PL328147A1 (en) Method of inhibiting colon tumours
PL332088A1 (en) Production of 1-butyl-4-piperidinylmethylamine
GB9516114D0 (en) Improved downhole apparatus
ZA97621B (en) Methods of inhibiting colon tumors
GB9603150D0 (en) Methods of inhibiting colon tumors
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles
EG24199A (en) Novel method of treatment
EG24157A (en) Novel method of treatment